Silverback Therapeutics Inc (SPRY) Insider Trading
- $40,545,225.66
- $64,785,315.17
- Aug. 21, 2025
- Sarina Tanimoto
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 25, 2024 | CEO | 95,267 | $9.12 | Sell | $868,835.04 | |
| March 22, 2024 | Insider | 2,343 | $9.02 | Sell | $21,133.86 | |
| March 21, 2024 | CEO | 472 | $9.00 | Sell | $4,248.00 | |
| March 19, 2024 | CEO | 1,918 | $9.03 | Sell | $17,319.54 | |
| March 15, 2024 | CEO | 96,756 | $9.14 | Sell | $884,349.84 | |
| March 14, 2024 | Insider | 444 | $9.00 | Sell | $3,996.00 | |
| March 13, 2024 | CEO | 2,800 | $9.00 | Sell | $25,200.00 | |
| Feb. 29, 2024 | CEO | 3,782 | $9.02 | Sell | $34,113.64 | |
| Feb. 28, 2024 | Insider | 98,778 | $9.02 | Sell | $890,977.56 | |
| Feb. 26, 2024 | Insider | 700 | $9.01 | Sell | $6,307.00 | |
| Sept. 28, 2023 | Insider | 40,000 | $3.62 | Buy | $144,800.00 | |
| Sept. 21, 2023 | Director | 2,700,000 | $3.03 | Buy | $8,181,000.00 | |
| Sept. 1, 2023 | Director | 100,000 | $7.71 | Sell | $771,000.00 | |
| Aug. 29, 2023 | Director | 3,750,000 | $6.20 | Buy | $23,250,000.00 | |
| Aug. 4, 2023 | Director | 18,897 | $7.06 | Sell | $133,412.82 | |
| Aug. 2, 2023 | Director | 36,281 | $7.09 | Sell | $257,232.29 | |
| July 6, 2023 | Director | 33,510 | $6.34 | Sell | $212,453.40 | |
| July 3, 2023 | Director | 26,520 | $6.72 | Sell | $178,214.40 | |
| June 1, 2023 | Director | 73,059 | $6.80 | Sell | $496,801.20 | |
| May 9, 2023 | Director | 42,900 | $5.31 | Sell | $227,799.00 | |
| Nov. 29, 2022 | CFO | 8,250 | $6.24 | Buy | $51,480.00 |
Insiders are both buying and selling Silverback Therapeutics Inc stock.
The insider traders at Silverback Therapeutics Inc are: Sarina Tanimoto, Richard E Lowenthal, Laura Shawver, Kathleen D Scott, Eric Karas, Justin Chakma, Ra Capital Management, L.P., Peter A Thompson, Alexander A Fitzpatrick, James E Flynn, Brian Dorsey, and Brent L. Saunders
The most active insider trader at Silverback Therapeutics Inc is Sarina Tanimoto with 15 trades.
James E Flynn has sold the most Silverback Therapeutics Inc stock with a total value of $36,859,647.32.
Ra Capital Management, L.P. has bought the most Silverback Therapeutics Inc stock with a total value of $45,302,235.32.
The most recent insider trade for Silverback Therapeutics Inc was on Aug. 21, 2025.
The single biggest insider buy for Silverback Therapeutics Inc was from Ra Capital Management, L.P. with a total value of $23,250,000.00 on Aug. 29, 2023.
The single biggest insider sell for Silverback Therapeutics Inc was from James E Flynn with a total value of $13,663,150.54 on June 27, 2025.